# Tamsulosin

## Harnalidge OCAS 0.4mg prolonged release

##### 

| 藥品代碼   | OHAR4                                                                                                                                                                                                                                              |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Treatment of signs and symptoms of benign prostatic hyperplasia (BPH)                                                                                                                                                                              |
| 用法用量   | Benign prostatic hyperplasia: Oral， Initial and maintenance: 0.4 mg once daily， may increase to 0.8 mg once daily.                                                                                                                               |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                       |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                       |
| 禁忌       | Hypersensitivity to tamsulosin or any component of the formulation                                                                                                                                                                                 |
| 副作用     | Cardiovascular: Orthostatic hypotension (6% to 19%) Central nervous system: Headache (19% to 21%)， dizziness (15% to 17%) Genitourinary: Abnormal ejaculation (8% to 18%) Respiratory: Rhinitis (13% to 18%) Miscellaneous: Infection (9% to 11%) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                             |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                               |

